Inhibitor Therapeutics (INTI) Total Current Liabilities (2012 - 2026)
Inhibitor Therapeutics (INTI) recorded Total Current Liabilities of $174,894 in Q2 2026, up 25.0% from $139,961 a year earlier but down 54.3% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Total Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics reported Total Current Liabilities of $766,330, up 8.0% from FY2024.
- Annual Total Current Liabilities has a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
- Across earlier years, Total Current Liabilities came in at $709,618 in FY2024 (+6.7%), $665,164 in FY2023 (-2.0%), $678,782 in FY2022 (-0.1%) and $679,630 in FY2021 (+59.8%).
- Quarterly Total Current Liabilities has ranged from $35,527 in Q2 2024 to $1.09 million in Q3 2022 over the past five years.
- On a year-over-year basis, Total Current Liabilities has increased for five consecutive quarters, with growth averaging 77.9% over the last eight quarters.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 303.7% in Q1 2026, against a decline of 95.3% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $382,320 (Q1 2026), $766,330 (Q4 2025) and $87,533 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 174,894.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 174,894.00 |
| Mar 31, 2026 | 382,320.00 |
| Dec 31, 2025 | 766,330.00 |
| Sep 30, 2025 | 87,533.00 |
| Jun 30, 2025 | 139,961.00 |
| Mar 31, 2025 | 94,712.00 |
| Dec 31, 2024 | 709,618.00 |
| Sep 30, 2024 | 44,559.00 |
| Jun 30, 2024 | 35,527.00 |
| Mar 31, 2024 | 155,850.00 |
| Dec 31, 2023 | 665,164.00 |
| Sep 30, 2023 | 156,440.00 |
| Jun 30, 2023 | 43,859.00 |
| Mar 31, 2023 | 78,443.00 |
| Dec 31, 2022 | 678,782.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 935,019.00 |
| Mar 31, 2022 | 830,214.00 |
| Dec 31, 2021 | 679,630.00 |
| Sep 30, 2021 | 590,892.00 |
API Access
Inhibitor Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();